Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

monoclonal antibody CC49-delta CH2

A humanized CH2 domain-deleted second-generation monoclonal antibody based on the antibody B72.3 that is directed against tumor-associated glycoprotein 72 (TAG72). TAG72 is expressed by gastric, breast, pancreatic, colorectal, and ovarian carcinoma cells.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	MOAB HCC49DCH2 MoAb HuCC49DeltaCH2 Monoclonal Antibody HCC49DCH2
Abbreviation:	MOAB CC49-deltaCH2
IND number:	9260
NSC code:	696081

monoclonal antibody CC49-delta CH2

Search NCI's Drug Dictionary